title: Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemia.
authors.forename: Y
authors.initials: Y
authors.lastname: Peñate
authors.forename: N
authors.initials: N
authors.lastname: Guillermo
authors.forename: B
authors.initials: B
authors.lastname: Hernández-Machín
authors.forename: T
authors.initials: T
authors.lastname: Montenegro
authors.forename: L
authors.initials: L
authors.lastname: Borrego
mesh_terms: D002908:Chronic Disease; D003561:Cytarabine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017730:Ki-1 Antigen / Q000187:drug effects* / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D012871:Skin Diseases / Q000139:chemically induced* / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents; D017730:Ki-1 Antigen; D003561:Cytarabine